바이오 제염 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of bio-decontamination Market

The global bio-decontamination market is witnessing steady growth as industries and healthcare facilities focus on eliminating harmful microorganisms to prevent infection and contamination. According to Fortune Business Insights, the market was valued at USD 219.9 million in 2025 and is projected to grow to USD 228.6 million in 2026. By 2034, the market is expected to reach USD 329.3 million, registering a CAGR of 4.70% during the forecast period from 2026 to 2034.

Market Overview and Growth Drivers

Bio-decontamination is a critical process in healthcare facilities, pharmaceutical production, and medical device manufacturing. It involves the use of physical and chemical methods to eliminate harmful microorganisms and ensure sterile conditions. The rising adoption of bio-decontamination solutions is largely fueled by the increasing number of hospital admissions, surgical procedures, and the prevalence of hospital-acquired infections (HAIs). North America dominated the market in 2025 with a 34.60% share, driven by stringent infection control regulations and growing investments in healthcare decontamination processes.

Pharmaceutical and medical device manufacturers, research organizations, and hospitals are investing significantly in bio-decontamination systems to ensure sterile end products. The growing focus on launching new drugs and medical devices under strict regulatory frameworks has further increased demand. For instance, the U.S. FDA approved 53 novel drugs in 2023, compared to 37 in 2022, compelling manufacturers to implement advanced decontamination procedures to meet safety standards.

COVID-19 Impact on the Market

The COVID-19 pandemic accelerated the adoption of bio-decontamination products. Increased demand for sterilization and disinfection in healthcare and pharmaceutical settings highlighted the importance of effective decontamination solutions. Companies such as TOMI Environmental Solutions, Inc. witnessed revenue growth of 249.3% in 2020 compared to 2019, reflecting the surge in demand. Post-pandemic, market growth stabilized, with TOMI reporting 7.5% growth in 2022 compared to 2021, as product utilization normalized.

Market Trends and Technological Integration

Market players are increasingly integrating advanced technologies to enhance efficiency. For example, Telstar introduced the Safety Airlock System (SAS) with its ionized Hydrogen Peroxide (ionHP+) system in September 2023, allowing a log 6 reduction in bioburden while minimizing material degradation. Such technological innovations continue to propel market growth, catering to aseptic pharmaceutical manufacturing and research environments.

Segment Analysis

• By Product: Equipment dominates the market, accounting for 80.23% in 2026 with a value of USD 183.4 million, due to regulatory requirements, technological advancements, and the growing need for automated decontamination systems. Consumables are expected to grow steadily with increasing availability and adoption in healthcare and pharmaceutical sectors.
• By Type: Chamber decontamination held a 55.03% share in 2026 (USD 125.8 million), driven by material transfer needs in drug manufacturing and research. Room decontamination methods are gaining traction to reduce hospital-acquired and surgical site infections.
• By Agent: Hydrogen peroxide is the leading decontamination agent, representing 62.82% in 2026 (USD 143.6 million) due to its safety and effectiveness. Chlorine dioxide is the second-largest segment, benefiting from increasing regulatory approvals for sterilization use.
• By End-user: Pharmaceutical & medical device manufacturers accounted for 63.47% of the market in 2026 (USD 145.1 million), supported by stringent guidelines for product safety. Hospitals, healthcare facilities, and research organizations are also significant adopters, driven by rising surgical procedures and infection prevention needs.

Regional Insights

North America led the market in 2025 with a value of USD 76.02 million, driven by high hospital admissions, surgical procedures, and adoption of decontamination practices. Europe follows, with the UK and Germany markets projected at USD 11.4 million and USD 15 million by 2026, respectively. Asia Pacific is expected to register the highest CAGR, with China at USD 14.5 million, Japan at USD 18.8 million, and India at USD 7.7 million by 2026, due to growing pharmaceutical manufacturing and infection control awareness.

Key Players and Strategic Developments

The market is semi-consolidated, with major players including STERIS (U.S.), Bioquell (U.K.), TOMI Environmental Solutions, Inc. (U.S.), and Amira Srl Unipersonale (Italy). Companies are focusing on strategic collaborations, product launches, and mergers & acquisitions to expand their footprint. Notable developments include STERIS launching next-generation vaporized hydrogen peroxide systems in 2021 and TOMI partnering with Cellares in 2023 to integrate iHP technology into cell therapy manufacturing.

Conclusion

The bio-decontamination market is poised for significant growth between 2025 and 2034, driven by increasing healthcare demands, regulatory pressures, and technological advancements. While product recalls and certain operational limitations may restrain growth, the rising focus on infection control, aseptic manufacturing, and research safety will continue to drive adoption across pharmaceutical, medical device, and healthcare sectors. North America will maintain its leadership, while Asia Pacific offers high-growth opportunities due to expanding manufacturing and heightened awareness regarding contamination prevention.

Segmentation By Product

• Equipment
• Consumables

By Type

• Chamber Decontamination
• Room Decontamination

By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

By End User

• Pharmaceutical & Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital & Healthcare Facilities
• Others

By Region

• North America (By Product, Type, Agent, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product, Type, Agent, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Product, Type, Agent, End-user, and Country/Sub-region)
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Rest of World (By Product, Type, Agent, and End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Technological Advancements in Bio-Decontamination Products
• 4.2. Key Industry Developments: Mergers, Partnership, Acquisitions
• 4.3. New Product Launches
• 4.4. Impact of COVID-19 on Bio-Decontamination Market

5. Global Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Equipment
  • 5.1.2. Consumables
• 5.2. Market Analysis, Insights and Forecast - By Agent
  • 5.2.1. Hydrogen Peroxide
  • 5.2.2. Chlorine Dioxide
  • 5.2.3. Peracetic Acid
  • 5.2.4. Nitrogen Dioxide
• 5.3. Market Analysis, Insights and Forecast - By Type
  • 5.3.1. Chamber Decontamination
  • 5.3.2. Room Decontamination
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Pharmaceutical & Medical Device Manufacturers
  • 5.4.2. Contract Manufacturing and Research Organizations
  • 5.4.3. Hospitals & Healthcare Facilities
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Rest of the World

6. North America Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Equipment
  • 6.1.2. Consumables
• 6.2. Market Analysis, Insights and Forecast - By Agent
  • 6.2.1. Hydrogen Peroxide
  • 6.2.2. Chlorine Dioxide
  • 6.2.3. Peracetic Acid
  • 6.2.4. Nitrogen Dioxide
• 6.3. Market Analysis, Insights and Forecast - By Type
  • 6.3.1. Chamber Decontamination
  • 6.3.2. Room Decontamination
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Pharmaceutical & Medical Device Manufacturers
  • 6.4.2. Contract Manufacturing and Research Organizations
  • 6.4.3. Hospitals & Healthcare Facilities
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Equipment
  • 7.1.2. Consumables
• 7.2. Market Analysis, Insights and Forecast - By Agent
  • 7.2.1. Hydrogen Peroxide
  • 7.2.2. Chlorine Dioxide
  • 7.2.3. Peracetic Acid
  • 7.2.4. Nitrogen Dioxide
• 7.3. Market Analysis, Insights and Forecast - By Type
  • 7.3.1. Chamber Decontamination
  • 7.3.2. Room Decontamination
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Pharmaceutical & Medical Device Manufacturers
  • 7.4.2. Contract Manufacturing and Research Organizations
  • 7.4.3. Hospitals & Healthcare Facilities
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Rest of Europe

8. Asia Pacific Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Equipment
  • 8.1.2. Consumables
• 8.2. Market Analysis, Insights and Forecast - By Agent
  • 8.2.1. Hydrogen Peroxide
  • 8.2.2. Chlorine Dioxide
  • 8.2.3. Peracetic Acid
  • 8.2.4. Nitrogen Dioxide
• 8.3. Market Analysis, Insights and Forecast - By Type
  • 8.3.1. Chamber Decontamination
  • 8.3.2. Room Decontamination
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Pharmaceutical & Medical Device Manufacturers
  • 8.4.2. Contract Manufacturing and Research Organizations
  • 8.4.3. Hospitals & Healthcare Facilities
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Rest of Asia Pacific

9. Rest of the World Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Equipment
  • 9.1.2. Consumables
• 9.2. Market Analysis, Insights and Forecast - By Agent
  • 9.2.1. Hydrogen Peroxide
  • 9.2.2. Chlorine Dioxide
  • 9.2.3. Peracetic Acid
  • 9.2.4. Nitrogen Dioxide
• 9.3. Market Analysis, Insights and Forecast - By Type
  • 9.3.1. Chamber Decontamination
  • 9.3.2. Room Decontamination
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Pharmaceutical & Medical Device Manufacturers
  • 9.4.2. Contract Manufacturing and Research Organizations
  • 9.4.3. Hospitals & Healthcare Facilities
  • 9.4.4. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. STERIS
    • 10.2.1.1. Overview
    • 10.2.1.2. Products
    • 10.2.1.3. SWOT analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. Bioquell (Ecolab)
    • 10.2.2.1. Overview
    • 10.2.2.2. Products
    • 10.2.2.3. SWOT analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. JCE Biotechnology
    • 10.2.3.1. Overview
    • 10.2.3.2. Products
    • 10.2.3.3. SWOT analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Fedegari Autoclavi S.p.A.
    • 10.2.4.1. Overview
    • 10.2.4.2. Products
    • 10.2.4.3. SWOT analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. TOMI Environmental Solutions, Inc.
    • 10.2.5.1. Overview
    • 10.2.5.2. Products
    • 10.2.5.3. SWOT analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. Amira Srl Unipersonale
    • 10.2.6.1. Overview
    • 10.2.6.2. Products
    • 10.2.6.3. SWOT analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Zhejiang Tailin Bioengineering Co., Ltd.
    • 10.2.7.1. Overview
    • 10.2.7.2. Products
    • 10.2.7.3. SWOT analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)
  • 10.2.8. Noxilizer, Inc.
    • 10.2.8.1. Overview
    • 10.2.8.2. Products
    • 10.2.8.3. SWOT analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. Financials (Based on Availability)
  • 10.2.9. ChlorDisys Solutions Inc.
    • 10.2.9.1. Overview
    • 10.2.9.2. Products
    • 10.2.9.3. SWOT analysis
    • 10.2.9.4. Recent Developments
    • 10.2.9.5. Strategies
    • 10.2.9.6. Financials (Based on Availability)